Predicted Trait | |
Reported Trait | Alzheimer's disease |
Mapped Trait(s) | Alzheimer disease (MONDO_0004975) |
Score Construction | |
PGS Name | GRS83_AD |
Development Method | |
Name | Genome-wide significant variants |
Parameters | excluding APOE |
Variants | |
Original Genome Build | GRCh38 |
Number of Variants | 83 |
Effect Weight Type | beta |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000309 |
Citation (link to publication) | Bellenguez C et al. Nat Genet (2022) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | European: 100% 487,511 individuals (100%) |
PGS Evaluation | European: 100% 5 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST90027158 |
[
|
European | NR |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM012966 | PSS009635| European Ancestry| 17,545 individuals |
PGP000309 | Bellenguez C et al. Nat Genet (2022) |
Reported Trait: Conversion to Alzheimer disease | HR: 1.076 [1.064, 1.088] | — | Hazard Ratio (HR; highest vs. lowest decile): 1.93 [1.75, 2.13] | Age, sex, number of APOE-ε4 and APOE-ε2 alleles and genetic principal components | Fixed-effect meta-analysis |
PPM012967 | PSS009634| European Ancestry| 4,114 individuals |
PGP000309 | Bellenguez C et al. Nat Genet (2022) |
Reported Trait: Conversion to Alzheimer disease (in mild cognitive impairment) | HR: 1.056 [1.04, 1.072] | — | Hazard Ratio (HR; highest vs. lowest decile): 1.63 [1.42, 1.87] | Age, sex, number of APOE-ε4 and APOE-ε2 alleles and genetic principal components | Fixed-effect meta-analysis |
PPM012968 | PSS009635| European Ancestry| 17,545 individuals |
PGP000309 | Bellenguez C et al. Nat Genet (2022) |
Reported Trait: Conversion to Alzheimer disease within 5 years | — | — | NRI (net reclassification improvement): 0.248 [0.159, 0.336] Delta C-index: 0.002 [0.0004, 0.004] |
Age, sex, number of APOE-ε4 and APOE-ε2 alleles and genetic principal components | Fixed-effect meta-analysis |
PPM012969 | PSS009635| European Ancestry| 17,545 individuals |
PGP000309 | Bellenguez C et al. Nat Genet (2022) |
Reported Trait: Conversion to Alzheimer disease within 3 years (in mild cognitive impairment) | — | — | NRI (net reclassification improvement): 0.232 [0.14, 0.325] Delta C-index: 0.007 [0.001, 0.012] |
Age, sex, number of APOE-ε4 and APOE-ε2 alleles and genetic principal components | Fixed-effect meta-analysis |
PPM022295 | PSS011907| European Ancestry| 3,285 individuals |
PGP000698 | Gorijala P et al. Alzheimers Dement (2023) |Ext. |
Reported Trait: Sporadic early-onset Alzheimer's disease | — | — | Odds ratio (OR, high vs low PGS tertile): 2.56 [1.95, 3.39] | Sex | — |
PPM022296 | PSS011906| European Ancestry| 4,303 individuals |
PGP000698 | Gorijala P et al. Alzheimers Dement (2023) |Ext. |
Reported Trait: Familial late-onset Alzheimer's disease | — | — | Odds ratio (OR, high vs low PGS tertile): 2.31 [1.97, 2.72] | Sex | — |
PPM022297 | PSS011908| European Ancestry| 5,149 individuals |
PGP000698 | Gorijala P et al. Alzheimers Dement (2023) |Ext. |
Reported Trait: Sporadic late-onset Alzheimer's disease | — | — | Odds ratio (OR, high vs low PGS tertile): 1.67 [1.46, 1.91] | Sex | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS009634 | — | — | 4,114 individuals | — | European | — | ADC | DCN, FACE, HAN, UAN, UHA, AMC, ZIM |
PSS009635 | — | — | 17,545 individuals | — | European | — | 3C, FHS, MAS, RS | AgeCoDe, VITA |
PSS011906 | — | — | [
|
— | European | — | NIA-LOAD | — |
PSS011907 | — | — | [
|
— | European | — | ADNI, Knight-ADRC | — |
PSS011908 | — | — | [
|
— | European | — | ADNI, Knight-ADRC | — |